V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16685797 | 330034506 | ELW | 18 | X724 | 1 | 2016-07-07 | MIDOSTAURIN | 330008594 | 330004079 | 330007276 |
| 16685798 | 330034506 | EOG20 | 200 | null | 1 | 2016-07-08 | IFOSFAMIDE | 330008594 | 330004079 | 330007276 |
| 16685799 | 330034507 | EJS03 | 225 | X723 | 1 | 2018-05-26 | CYTARABINE | 330008614 | 330012395 | 330007279 |
| 16685800 | 330034508 | ERS12 | 0 | null | 1 | 2016-10-25 | IFOSFAMIDE | 330008744 | 330004090 | 330007293 |
| 16685801 | 330034509 | EW100 | 2450 | X722 | 1 | 2015-08-15 | CETUXIMAB | 330008813 | 330004096 | 330007300 |
| 16685802 | 330034509 | EOI | 1800 | Tr | 1 | 2015-08-15 | FLUDARABINE | 330008813 | 330004096 | 330007300 |
| 16685803 | 330034509 | EKY01 | 0 | X724 | 2 | 2015-08-22 | BORTEZOMIB | 330008813 | 330004096 | 330007300 |
| 16685804 | 330034510 | ECN | 86 | null | 1 | 2017-12-06 | CETUXIMAB | 330008821 | 330004097 | 330007301 |
| 16685805 | 330034511 | ECL02 | null | X724 | 1 | 2014-11-03 | TREMELIMUMAB | 330008859 | 330004101 | 330007304 |
| 16685806 | 330034512 | ECL02 | 320 | X721 | 5 | 2015-05-08 | PACLITAXEL | 330008887 | 330004103 | 330007308 |
| 16685807 | 330034516 | ECL02 | null | null | 1 | 2016-08-05 | CETUXIMAB | 330008964 | 330012400 | 330007321 |
| 16685808 | 330034516 | EQ8 | 1000 | X721 | 1 | 2016-08-12 | IFOSFAMIDE | 330008964 | 330012400 | 330007321 |
| 16685809 | 330034516 | EOI | 27.5 | X721 | 1 | 2016-08-12 | PEMETREXED | 330008964 | 330012400 | 330007321 |
| 16685810 | 330034516 | ED617 | 70 | X724 | 1 | 2016-08-12 | NOT CHEMO | 330008964 | 330012400 | 330007321 |
| 16685812 | 330034519 | EW100 | 12.5 | X721 | 1 | 2015-06-08 | METHOTREXATE | 330009102 | 330004145 | 330007344 |
| 16685813 | 330034519 | EQ8 | 1800 | X724 | 2 | 2015-06-08 | IFOSFAMIDE | 330009102 | 330004145 | 330007344 |
| 16685814 | 330034519 | EOG20 | 3600 | null | 1 | 2015-06-09 | BORTEZOMIB | 330009102 | 330004145 | 330007344 |
| 16685815 | 330034519 | EGENG | 450 | X721 | 2 | 2015-06-09 | FLUDARABINE | 330009102 | 330004145 | 330007344 |
| 16685816 | 330034519 | ETG | 185 | X724 | 1 | 2015-06-09 | PERTUZUMAB | 330009102 | 330004145 | 330007344 |
| 16685817 | 330034519 | EUZ | 1020 | null | 1 | 2015-06-09 | TEMOZOLOMIDE | 330009102 | 330004145 | 330007344 |
| 16685818 | 330034520 | ECL02 | 487.5 | X724 | 2 | 2013-11-22 | CAPECITABINE | 330009140 | 330008270 | 330007353 |
| 16685819 | 330034520 | EGENG | 1000 | null | 1 | 2013-11-23 | TEMOZOLOMIDE | 330009140 | 330008270 | 330007353 |
| 16685820 | 330034520 | EEI00 | 6.25 | null | 1 | 2013-11-23 | TEMOZOLOMIDE | 330009140 | 330008270 | 330007353 |
| 16685821 | 330034521 | EW100 | 1500 | X721 | 1 | 2016-04-26 | FLUOROURACIL | 330009140 | 330004152 | 330007355 |
| 16685822 | 330034521 | ED617 | 10 | X724 | 1 | 2016-04-26 | NELARABINE | 330009140 | 330004152 | 330007355 |
| 16685823 | 330034521 | EEI00 | 1.5 | X724 | 5 | 2016-04-27 | TEMOZOLOMIDE | 330009140 | 330004152 | 330007355 |
| 16685824 | 330034521 | ECL01 | 0 | X724 | 1 | 2016-04-28 | IRINOTECAN | 330009140 | 330004152 | 330007355 |
| 16685825 | 330034521 | EEI00 | 350 | X724 | 1 | 2016-04-28 | TRASTUZUMAB | 330009140 | 330004152 | 330007355 |
| 16685826 | 330034521 | EKY01 | 8 | X724 | 1 | 2016-05-05 | CETUXIMAB | 330009140 | 330004152 | 330007355 |
| 16685827 | 330034521 | EX950 | 600 | X724 | 2 | 2016-05-06 | FLUDARABINE | 330009140 | 330004152 | 330007355 |
| 16685828 | 330034521 | EUDUU | 2200 | X729 | 1 | 2016-05-07 | IFOSFAMIDE | 330009140 | 330004152 | 330007355 |
| 16685829 | 330034521 | ELW | 1.5 | X723 | 1 | 2016-05-07 | RITUXIMAB | 330009140 | 330004152 | 330007355 |
| 16685830 | 330034523 | EJS03 | 487.5 | x723 | 1 | 2015-07-31 | ETOPOSIDE | 330010452 | 330004223 | 330007413 |
| 16685831 | 330034523 | ED617 | 1 | X721 | 1 | 2015-08-01 | CYCLOPHOSPHAMIDE | 330010452 | 330004223 | 330007413 |
| 16685832 | 330034523 | EZ1 | 150 | X721 | 1 | 2015-08-02 | NOT CHEMO | 330010452 | 330004223 | 330007413 |
| 16685833 | 330034524 | ECL02 | 7200 | X721 | 1 | null | CYCLOPHOSPHAMIDE | 330010826 | 330004259 | 330007452 |
| 16685834 | 330034524 | ERA20 | 0 | null | 1 | null | ETOPOSIDE | 330010826 | 330004259 | 330007452 |
| 16685835 | 330034524 | EQ8 | 3.25 | X721 | 1 | null | CISPLATIN | 330010826 | 330004259 | 330007452 |
| 16685836 | 330034525 | EKU01 | 110 | X721 | 1 | 2019-01-04 | THALIDOMIDE | 330010880 | 330004265 | 330007458 |
| 16685837 | 330034525 | EZ1 | 460 | X724 | 1 | 2019-01-07 | ETOPOSIDE | 330010880 | 330004265 | 330007458 |
| 16685838 | 330034525 | EUZ | 60 | X724 | 1 | 2019-01-07 | QUIZARTINIB | 330010880 | 330004265 | 330007458 |
| 16685839 | 330034527 | EGENG | 170 | X724 | 2 | 2018-01-29 | OXALIPLATIN | 330011174 | 330004306 | 330007489 |
| 16685840 | 330034528 | EGENG | 275 | null | 1 | 2015-09-01 | NOT CHEMO | 330011387 | 330012420 | 330007513 |
| 16685841 | 330034528 | ECL01 | 155 | X721 | 1 | 2015-09-02 | LOMUSTINE | 330011387 | 330012420 | 330007513 |
| 16685842 | 330034529 | EQ3 | 555 | X723 | 1 | 2016-05-08 | NOT CHEMO | 330011707 | 330008392 | 330007552 |
| 16685843 | 330034530 | EUZ | 140 | null | 1 | 2016-10-09 | CYCLOPHOSPHAMIDE | 330011956 | 330004434 | 330007603 |
| 16685844 | 330034532 | EUH | 600 | X722 | 2 | null | NOT CHEMO | 330012134 | 330004472 | 330007640 |
| 16685845 | 330034532 | ECL01 | 15000 | null | 1 | null | TEMOZOLOMIDE | 330012134 | 330004472 | 330007640 |
| 16685846 | 330034532 | EUZ | 4 | X724 | 2 | null | NOT CHEMO | 330012134 | 330004472 | 330007640 |
| 16685847 | 330034533 | EJR | 400 | X724 | 2 | 2015-06-20 | ETOPOSIDE | 330012411 | 330004549 | 330007715 |